Aging and drug discovery
Next generation sequencing technologies for aging and drug discovery - Alla Lapidus
New biomarkers and interventions in aging - Alexey Moskalev
Artificial intelligence and blockchain in healthcare
The Gene-Chain, a commercial blockchain genomics platform - Maurizio Viviani
Exonum framework for blockchain projects in Healthcare - G. Givishvili
How can pharmaceutical R&D learn from cats and cars? - V. de Biasi
Deep learning in Computational Pathology - Thomas J. Fuchs
Blockchains for genome data management - Daniel Burgwinkel
Blockchains in production use in healthcare - I. Lomus
|
Digital biomarkers
Digital biomarkers for neurological disorders - Ray Dorsey
Medicinal Chemistry
Screening small-molecule libraries for Gram negative active compounds. Opportunities and pitfalls - Daniel Ritz
Biophysics in drug discovery - Michael Hennig
Microfluidics
Picking the right microfluidics device material for in vitro diagnostics - balancing performance and cost with glass - Alexios Paul Tzannis
Advanced ceramics: a high performance option for microfluidics? - Senad Hasanovic
Innovating MedComms
Reproducibility and reuse of scientific code - Pierre Montagano
Peptide Therapeutics
Palladium in peptide/protein synthesis and modification - Ashraf Brik
Synthetically difficult peptide therapeutics: increasing purity and yield of SPPS using parallel synthesis optimization - Andrew Kennedy
Artificial intelligence designed TLR4 peptide activators - Amit Michaeli
Rapid Fire Session
Network analysis of induced pluripotent stem cells secretome indicate reveals macrophage dependent anti fibrotic action in rat lung injury model - Cedric Simillion
High-Content Assay for Morphological Characterization of 3D Neuronal Networks in Microfluidic Platform - Oksana Sirenko
Blockchain-Enabled Open Data Framework Fostering Collaborative Research - Sebastian Bürgel
Biofabrication of 3D tissue models by assembling cell-laden hydrogel units - Shintaroh Iwanaga
Stem Cells
A resource of conditional knockouts in human stem cells - Bill Skarnes
Introduction of desired mutations in human pluripotent stem cells and the spectre of undesired culture-acquired mutations - Florian Merkle
Modelling neuroinflammation using human induced pluripotent stem cell-derived microglia - Sally Cowley